Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hannah M Jones

Showing results (11-20 of 93) with videos related to

Pageof 10
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 22, 2004
Quantitative prediction of the in vivo inhibition of diazepam metabolism by omeprazole using rat liver microsomes and hepatocytesHannah M Jones, David Hallifax, J Brian Houston
Clinical Pharmacokinetics|April 28, 2006
A novel strategy for physiologically based predictions of human pharmacokineticsHannah M Jones, Neil Parrott, Karin Jorga, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 13, 2022
Physiologically Based Pharmacokinetic Modeling To Predict Drug-Biologic Interactions with Cytokine Modulators: Are These Relevant and Is Interleukin-6 Enough?Kuan-Fu Chen, Hannah M Jones, Katherine L Gill
The AAPS Journal|March 13, 2009
Modelling and PBPK simulation in drug discoveryHannah M Jones, Iain B Gardner, Kenny J Watson
Clinical Pharmacokinetics|November 23, 2006
Predicting pharmacokinetic food effects using biorelevant solubility media and physiologically based modellingHannah M Jones, Neil Parrott, Gerd Ohlenbusch, et al.
European Journal of Drug Metabolism and Pharmacokinetics|June 18, 2021
A Physiologically Based Pharmacokinetic and Drug-Drug Interaction Model for the CB2 Agonist LenabasumQiang Fu, Hannah M Jones, Gang Sun, et al.
Journal of Clinical Pharmacology|September 23, 2024
Determination of Vatiquinone Drug-Drug Interactions, as CYP450 Perpetrator and Victim, Using Physiologically Based Pharmacokinetic (PBPK) Modeling and SimulationLucy Lee, Noriko Okudaira, Katsuyuki Murase, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 19, 2011
Measurement of binding of basic drugs to acidic phospholipids using surface plasmon resonance and incorporation of the data into mechanistic tissue composition equations to predict steady-state volume of distributionHelen Small, Iain Gardner, Hannah M Jones, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 21, 2002
Incorporating measures of variability and uncertainty into the prediction of in vivo hepatic clearance from in vitro dataIvan Nestorov, Ivelina Gueorguieva, Hannah M Jones, et al.
Mabs|April 7, 2016
A mechanistic PK/PD model for two anti-IL13 antibodies explains the difference in total IL-13 accumulation observed in clinical studiesAbhinav Tiwari, Marion Kasaian, Anne C Heatherington, et al.
Pageof 10

Showing results (11-20 of 93) with videos related to

Sort By:
Pageof 10
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 22, 2004
Quantitative prediction of the in vivo inhibition of diazepam metabolism by omeprazole using rat liver microsomes and hepatocytesHannah M Jones, David Hallifax, J Brian Houston
Clinical Pharmacokinetics|April 28, 2006
A novel strategy for physiologically based predictions of human pharmacokineticsHannah M Jones, Neil Parrott, Karin Jorga, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 13, 2022
Physiologically Based Pharmacokinetic Modeling To Predict Drug-Biologic Interactions with Cytokine Modulators: Are These Relevant and Is Interleukin-6 Enough?Kuan-Fu Chen, Hannah M Jones, Katherine L Gill
The AAPS Journal|March 13, 2009
Modelling and PBPK simulation in drug discoveryHannah M Jones, Iain B Gardner, Kenny J Watson
Clinical Pharmacokinetics|November 23, 2006
Predicting pharmacokinetic food effects using biorelevant solubility media and physiologically based modellingHannah M Jones, Neil Parrott, Gerd Ohlenbusch, et al.
European Journal of Drug Metabolism and Pharmacokinetics|June 18, 2021
A Physiologically Based Pharmacokinetic and Drug-Drug Interaction Model for the CB2 Agonist LenabasumQiang Fu, Hannah M Jones, Gang Sun, et al.
Journal of Clinical Pharmacology|September 23, 2024
Determination of Vatiquinone Drug-Drug Interactions, as CYP450 Perpetrator and Victim, Using Physiologically Based Pharmacokinetic (PBPK) Modeling and SimulationLucy Lee, Noriko Okudaira, Katsuyuki Murase, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 19, 2011
Measurement of binding of basic drugs to acidic phospholipids using surface plasmon resonance and incorporation of the data into mechanistic tissue composition equations to predict steady-state volume of distributionHelen Small, Iain Gardner, Hannah M Jones, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 21, 2002
Incorporating measures of variability and uncertainty into the prediction of in vivo hepatic clearance from in vitro dataIvan Nestorov, Ivelina Gueorguieva, Hannah M Jones, et al.
Mabs|April 7, 2016
A mechanistic PK/PD model for two anti-IL13 antibodies explains the difference in total IL-13 accumulation observed in clinical studiesAbhinav Tiwari, Marion Kasaian, Anne C Heatherington, et al.
Pageof 10